• Report SKU:SKU: HVR3354
  • Description
  • Table of Contents
  • Request Sample

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2016 to 2027 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides: ●  Market Sizing estimations and forecasts across the given market segments ●  Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, ) ●  Strategic recommendations in key business segments based on the market estimations ●  Regional and country level market analysis ●  Competitive landscaping of major market players ●  Company profiling covering the financials, recent activities and the future strategies

1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research Sources
1.4.2 Primary Research Sources
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Vaccines Market by Distribution Channel
5.1 Introduction
5.2 Government Suppliers
5.3 Hospital & Retial Pharmacies

6 Vaccines Market by Type
6.1 Introduction
6.2 Multivalent Vaccines
6.3 Monovalent Vaccines

7 Vaccines Market by Patient Type
7.1 Introduction
7.2 Adult Patients
7.3 Pediatric Patients
7.4 Traveler Vaccines

8 Vaccines Market by Route of Administration
8.1 Introduction
8.2 Intradermal
8.3 Intramuscular (IM)
8.4 Oral
8.5 Subcutaneous (SC)

9 Vaccines Market by Disease Indication
9.1 Introduction
9.2 Cancer
9.3 Cholera
9.4 Dengue
9.5 Diphtheria, Pertussis, and Tetanus (DTP)
9.6 Hepatitis
9.7 Herpes Zoster
9.8 Human Papilloma Virus (HPV)
9.9 Influenza
9.10 Measles, Mumps, and Rubella (MMR)
9.11 Meningococcal Disease
9.12 Pneumococcal Disease
9.13 Polio
9.14 Rabies
9.15 Rotavirus
9.16 Typhoid Fever
9.17 Varicella

10 Vaccines Market by Technology
10.1 Introduction
10.2 Conjugate Vaccines
10.3 Inactivated & Subunit Vaccines
10.4 Live Attenuated Vaccines
10.5 Polysaccharide Vaccines
10.6 Recombinant Vaccines
10.7 Toxoid Vaccines
10.8 Viral Vaccines

11 Geographical Segmentation
11.1 North America
11.1.1 US
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 UK
11.2.5 Spain
11.2.6 Rest of Europe
11.3 Asia Pacific
11.3.1 Japan
11.3.2 China
11.3.3 India
11.3.4 Australia
11.3.5 New Zealand
11.3.6 Rest of Asia Pacific
11.4 South America
11.4.1 Argentina
11.4.2 Brazil
11.4.3 Venezuela
11.4.4 Chile
11.4.5 Peru
11.5 Middle East & Africa
11.5.1 UAE
11.5.2 Saudi Arabia
11.5.3 Qatar
11.5.4 Iran
11.5.5 South Africa
11.5.6 Rest of Middle East & Africa

12 Vendor Landscaping
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiles
13.1 Glaxosmithkline PLC
13.2 Pfizer Inc
13.3 Merck & Co Inc
13.4 Sanofi Pasteur SA
13.5 CSL Limited
13.6 Emergent Biosolutions Inc
13.7 Johnson & Johnson
13.8 Astrazeneca
13.9 Serum Institute of India Pvt LTD
13.10 Bavarian Nordic
13.11 Mitsubishi Tanabe Pharma Corporation
13.12 Daiichi Sankyo Company Limited
13.13 Panacea Biotec LTD
13.14 Biological E
13.15 Bharat Biotech

14 Appendix

15 Disclaimer

List of Tables
Table 1 Global Vaccines Market Analysis, by Region, (2017-2027) ($MN)
Table 2 Global Vaccines Market Analysis, by Distribution Channel, (2017-2027) ($MN)
Table 3 Global Vaccines Market Analysis, by Government Suppliers, (2017-2027) ($MN)
Table 4 Global Vaccines Market Analysis, by Hospital & Retial Pharmacies, (2017-2027) ($MN)
Table 5 Global Vaccines Market Analysis, by Type, (2017-2027) ($MN)
Table 6 Global Vaccines Market Analysis, by Multivalent Vaccines, (2017-2027) ($MN)
Table 7 Global Vaccines Market Analysis, by Monovalent Vaccines, (2017-2027) ($MN)
Table 8 Global Vaccines Market Analysis, by Patient Type, (2017-2027) ($MN)
Table 9 Global Vaccines Market Analysis, by Adult Patients, (2017-2027) ($MN)
Table 10 Global Vaccines Market Analysis, by Pediatric Patients, (2017-2027) ($MN)
Table 11 Global Vaccines Market Analysis, by Traveler Vaccines, (2017-2027) ($MN)
Table 12 Global Vaccines Market Analysis, by Route of Administration, (2017-2027) ($MN)
Table 13 Global Vaccines Market Analysis, by Intradermal, (2017-2027) ($MN)
Table 14 Global Vaccines Market Analysis, by Intramuscular (IM), (2017-2027) ($MN)
Table 15 Global Vaccines Market Analysis, by Oral, (2017-2027) ($MN)
Table 16 Global Vaccines Market Analysis, by Subcutaneous (SC), (2017-2027) ($MN)
Table 17 Global Vaccines Market Analysis, by Disease Indication, (2017-2027) ($MN)
Table 18 Global Vaccines Market Analysis, by Cancer, (2017-2027) ($MN)
Table 19 Global Vaccines Market Analysis, by Cholera, (2017-2027) ($MN)
Table 20 Global Vaccines Market Analysis, by Dengue, (2017-2027) ($MN)
Table 21 Global Vaccines Market Analysis, by Diphtheria, Pertussis, and Tetanus (DTP), (2017-2027) ($MN)
Table 22 Global Vaccines Market Analysis, by Hepatitis, (2017-2027) ($MN)
Table 23 Global Vaccines Market Analysis, by Herpes Zoster, (2017-2027) ($MN)
Table 24 Global Vaccines Market Analysis, by Human Papilloma Virus (HPV), (2017-2027) ($MN)
Table 25 Global Vaccines Market Analysis, by Influenza, (2017-2027) ($MN)
Table 26 Global Vaccines Market Analysis, by Measles, Mumps, and Rubella (MMR), (2017-2027) ($MN)
Table 27 Global Vaccines Market Analysis, by Meningococcal Disease, (2017-2027) ($MN)
Table 28 Global Vaccines Market Analysis, by Pneumococcal Disease, (2017-2027) ($MN)
Table 29 Global Vaccines Market Analysis, by Polio, (2017-2027) ($MN)
Table 30 Global Vaccines Market Analysis, by Rabies, (2017-2027) ($MN)
Table 31 Global Vaccines Market Analysis, by Rotavirus, (2017-2027) ($MN)
Table 32 Global Vaccines Market Analysis, by Typhoid Fever, (2017-2027) ($MN)
Table 33 Global Vaccines Market Analysis, by Varicella, (2017-2027) ($MN)
Table 34 Global Vaccines Market Analysis, by Technology, (2017-2027) ($MN)
Table 35 Global Vaccines Market Analysis, by Conjugate Vaccines, (2017-2027) ($MN)
Table 36 Global Vaccines Market Analysis, by Inactivated & Subunit Vaccines, (2017-2027) ($MN)
Table 37 Global Vaccines Market Analysis, by Live Attenuated Vaccines, (2017-2027) ($MN)
Table 38 Global Vaccines Market Analysis, by Polysaccharide Vaccines, (2017-2027) ($MN)
Table 39 Global Vaccines Market Analysis, by Recombinant Vaccines, (2017-2027) ($MN)
Table 40 Global Vaccines Market Analysis, by Toxoid Vaccines, (2017-2027) ($MN)
Table 41 Global Vaccines Market Analysis, by Viral Vaccines, (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.